Degenerative cervical myelopathy (DCM) is a common non-traumatic spinal cord disorder and characterized by progressive neurological impairment. Generally, it is still underdiagnosed and referral to spine specialists is often late, when patients already present with incomplete cervical spinal cord injury (SCI). To improve early diagnosis and accelerate referral, diagnostic criteria for DCM are required. Recently, AO Spine RECODE- DCM (REsearch Objectives and Common Data Elements for Degenerative Cervical Myelopathy) (aospine.org/recode), an international, interdisciplinary and interprofessional initiative, including patients with DCM, was funded with the aim to accelerate knowledge discovery that can change outcomes. In this perspective we advocate for the participation of SCI specialists in this process, where the expertise and perspective on this disorder and requirements for the diagnostic and therapeutic work up is well developed.
publisher-imprint-nameSpringer Naturevolume-issue-count12issue-article-count12issue-toc-levels0issue-pricelist-year2021issue-copyright-holderInternational Spinal Cord Societyissue-copyright-year2021article-contains-esmNoarticle-numbering-styleUnnumberedarticle-registration-date-year2021article-registration-date-month9article-registration-date-day15article-toc-levels0toc-levels0volume-typeRegularjournal-productNonStandardArchiveJournalnumbering-styleUnnumberedarticle-grants-typeOpenChoicemetadata-grantOpenAccessabstract-grantOpenAccessbodypdf-grantOpenAccessbodyhtml-grantOpenAccessbibliography-grantOpenAccessesm-grantOpenAccessonline-firstfalsepdf-file-referenceBodyRef/PDF/41393_2021_Article_711.pdfpdf-typeTypesettarget-typeOnlinePDFissue-online-date-year2021issue-online-date-month11issue-online-date-day2issue-print-date-year2021issue-print-date-month10issue-print-date-day26issue-typeRegulararticle-typeReviewPaperjournal-subject-primaryBiomedicinejournal-subject-secondaryBiomedicine, generaljournal-subject-secondaryNeurosciencesjournal-subject-secondaryAnatomyjournal-subject-secondaryHuman Physiologyjournal-subject-secondaryNeurochemistryjournal-subject-secondaryNeuropsychologyjournal-subject-collectionBiomedical and Life Sciencesopen-accesstrue
Lists of authors and their affiliations appear at the end of the paper.
Perspective
Degenerative cervical myelopathy (DCM) (historically termed “cervical spondylotic myelopathy” [CSM]) is the most common non-traumatic, progressive spinal cord disorder with an estimated 2% prevalence [1]. The disorder is indeed imprecisely and insufficiently characterized by neck and radicular pain, fine motor dysfunction, gait instability, and bladder dysfunction and for most lacks common diagnostic criteria [2]. If not recognized and treated timely, patients may eventually present as incomplete cervical spinal cord injury (SCI). This letter aims to raise awareness of these shortcomings in the neurological community and emphasize an ongoing initiative to improve clinical care and foster global research [3]. The neurological field should not be left out in this effort.
Due to a variety of symptoms, patients eventually get referred to different specialists, commonly orthopedics, neurosurgeons, neurologists, or physiotherapists. While surgical decompression of the encroached spinal cord is recommended in patients experiencing already moderate/severe, or progressive symptoms, the goal of enabling earlier and/or preventative treatment has now been defined as a priority research need. In its early stages, DCM is frequently underdiagnosed or misdiagnosed as carpal tunnel syndrome or peripheral neuropathy, until patients develop more severe impairments of upper and lower limb function urging the consideration of incomplete cervical SCI. Given that DCM is a progressive but preventable neurological condition, the delayed diagnosis and late referral for evaluation of surgical decompression, can lead to poorer neurological outcomes [4]. In addition, the pre-operative neurological status significantly influences post-operative recovery [5]. Therefore, an early diagnosis is important to achieve good clinical results. The diagnosis of DCM is currently based on clinical signs and symptoms, eventually complemented by cervical spine MRI. However, there is still no consensus on diagnostic criteria for DCM, leading to ambiguous, descriptive clinical diagnoses, and heterogenous definitions of DCM applied in clinical studies [6, 7]. Furthermore, as demonstrated in the UK, DCM is rarely covered in the medical curriculum [8]. AO Spine RECODE-DCM (REsearch Objectives and Common Data Elements for Degenerative Cervical Myelopathy) (aospine.org/recode) is an international, interdisciplinary, and interprofessional initiative, including patients with DCM, which aims to accelerate knowledge discovery that can change outcomes [9]. This has included the formation of research priorities such as the development of common diagnostic criteria. Alongside its importance for clinical care, a sensitive and specific set of diagnostic criteria is required to foster research, particularly for those studies aiming at investigating neuroprotective strategies. Diagnostic criteria for DCM can help to overcome several shortcomings in patient care and research (Fig. 1). The development of diagnostic criteria for DCM would benefit from the experiences of the neurological community; a UK cohort study identified 45% of cases are initially diagnosed by Neurologists, whilst Neurologists are familiar with their development and implementation [10]. Common criteria will help the dialog between neurologists, general practitioners (primary care providers), and spine specialists, and propagate the knowledge of red flags in DCM that require timely and specific actions, before established SCI. The development of diagnostic criteria involves both comprehensive diagnostic criteria for research and spine specialists, as well as easily applicable algorithms that speed up referral to cervical spine MRI and spine specialists. We have established an initial working group to act upon this opportunity (AO Spine RECODE DCM Diagnostic Criteria Incubator). If you are interested in contributing to this process, please contact us.
Infographic providing an overview why diagnostic criteria for DCM are needed.
The panels summarize shortcomings in patient care and research which diagnostic criteria for DCM can help to overcome.
Author contributions
CZ and BD: conceptualisation; CZ, KM, KP, AC, MF, IS, LT, BD: investigation; AC, MF, BD: supervision; CZ, IS, BD: visualisation; CZ and BD: writing—original draft; CZ, KM, KP, AC, MF, IS, LT, BD: writing—review and editing.
Funding
Open Access funding provided by Universität Zürich.
Competing interests
The authors declare no competing interests.
ReferencesSmithSSStewartMEDaviesBMKotterMRNThe prevalence of asymptomatic and symptomatic spinal cord compression on magnetic resonance imaging: a systematic review and meta-analysis20211159760710.1177/2192568220934496BadhiwalaJHAhujaCSAkbarMAWitiwCDNassiriFFurlanJCDegenerative cervical myelopathy - update and future directions2020161082410.1038/s41582-019-0303-0GrodzinskiBBestwickHBhattiFDurhamRKhanMPartha SarathiCIResearch activity amongst DCM research priorities20211631561810.1007/s00701-021-04767-6PopeDHMowforthODDaviesBMKotterMRNDiagnostic delays lead to greater disability in degenerative cervical myelopathy and represent a health inequality2020453687710.1097/BRS.0000000000003305TetreaultLKopjarBCôtéPArnoldPFehlingsMGA clinical prediction rule for functional outcomes in patients undergoing surgery for degenerative cervical myelopathy: analysis of an international prospective multicenter data set of 757 subjects20159720384610.2106/JBJS.O.00189DaviesBMMcHughMElgherianiAKoliasAGTetreaultLHutchinsonPJAThe reporting of study and population characteristics in degenerative cervical myelopathy: a systematic review201712e017256410.1371/journal.pone.01725641:CAS:528:DC%2BC1cXntl2qKhanDZKhanMSKotterMRDaviesBMTackling research inefficiency in degenerative cervical myelopathy: illustrative review20209e15922-e10.2196/15922WaqarMWilcockJGarnerJDaviesBKotterMQuantitative analysis of medical students’ and physicians’ knowledge of degenerative cervical myelopathy202010e02845510.1136/bmjopen-2018-028455DaviesBMKhanDZMowforthODMcNairAGKGronlundTKoliasAGRE-CODE DCM (REsearch Objectives and Common Data Elements for Degenerative Cervical Myelopathy): a consensus process to improve research efficiency in DCM, through establishment of a standardized dataset for clinical research and the definition of the research priorities2019965S76S10.1177/2192568219832855HiltonBTempest-MitchellJDaviesBKotterMRoute to diagnosis of degenerative cervical myelopathy in a UK healthcare system: a retrospective cohort study20199e02700010.1136/bmjopen-2018-027000
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.